Haemonetics Corporation (NYSE:HAE) headquartered in Braintree, will host a conference call for the investment community to discuss the 2Q21 financial results on 4th November 2020 at 8:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.haemonetics.com
Earnings Expectation
Haemonetics Corporation is expected to report second quarter earnings results, before market open, on Wednesday 4th November 2020. Analysts polled by Thomson Reuters anticipate second quarter income of $ 0.51 per share from revenue of $ 207.65 million. Looking ahead, the full year income are expected at $ 2.46 per share on the revenues of $ 869.34 million.
Haemonetics Corporation, a healthcare company, provides hematology products and solutions. It operates through Japan, EMEA, North America Plasma, and All Other segments. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables, such as plasma collection containers and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system.
